Culture Development Industry News

1. DSM Announces License Agreement With Amgen For Use Of DSM's XD® Cell Culture Patents 1/15/2013

   DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed a non-exclusive license agreement with Amgen Inc. for access to DSM's proprietary XD® high cell density process patents.

2. Cell Culture - Rising Demand For Biologics And Growing Visibility Of Approval Pathway For Biosimilars Will Create Growth Opportunities 11/19/2012

   GBI Research, the leading business intelligence provider, has released its latest research "Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities", which provides in-depth analysis on the processes, drivers and barriers of the cell culture market.